Vigmed Holding AB announces new dates for publication of the Annual Report 2016 and the Annual General Meeting

The Board of Directors of Vigmed Holding AB have decided to postpone the publication of the Annual Report for financial year 2016 to 30 May 2017. The Board of Director have also decided to postpone the Annual General Meeting. The Annual General Meeting is planned to be held at Vigmed’s office in Helsingborg on 20 June 2017, 2:00 p.m.

The Annual Report 2016 was initially planned to be published on 7 April 2017 and the Annual General Meeting was initially planned to be held on 11 May 2017.  

 

For further information contact:
Chairman of the Board Sten Dahlborg, +46 708-369 419
CEO Henrik Olsen, +46 763-497 364

     
This is a translation of the Swedish version. When in doubt, the Swedish wording prevails.
 

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor.Additional information about the company can be found on Vigmed’s website:   www.vigmed.com/investor


Tags:

About Us

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and the company has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information can be found on Vigmed’s home page: www.vigmed.com

Subscribe

Documents & Links